$CBRS

Lie Sean sold $151.1M of CBRS

Lie Sean (Chief Technology Officer) sold 726,540 shares of Cerebras Systems Inc. (CBRS) at an average of $207.90 ($203.78–$212.64, $151.05M total) across 11 trades over 2026-08-20 to 2026-08-21 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Lie Sean
Published Aug 22, 2026, 12:58 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 22, 2026, 1:07 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CBRS
Bearish
high confidence
Mentioned
$CBRS
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CBRSBearishMed
01

Why it matters

The $151M sale reduces insider ownership and may be interpreted as a negative signal, but could also be a scheduled liquidity event.

02

Market read

Primary insider sale provides fresh material for traders; relevance is moderate to high for short‑term positioning.

03

What to watch

Potential upcoming product launch or financing event that prompted the pre‑arranged sale.

Relevance 7/10Novelty 8/10Timing: filing disclosed today (2026‑08‑22)

Background

SEC Form 4 filing discloses an insider transaction by Cerebras CTO Lie Sean.

Company-level read

Ticker impact

$CBRSBearishHigh confidence
Context

CTO Lie Sean sold 726,540 shares for $151.1M via a 10b5‑1 plan, reducing his stake to 368,926 shares.

Expected impact

Possible short‑term dip of 2‑4% as market digests the sizable sale.

Evidence & confidence

The sale size ($151M) is material for a mid‑cap AI chip maker; insider sales often precede price weakness.

Market effects

May raise concerns for AI‑hardware sector if other insiders follow suit.

Limited to US tech equities; no broader regional effect.

Minimal global impact beyond investors tracking Cerebras.

Counterpoint

The sale could be a routine 10b5‑1 execution unrelated to fundamentals.

Key entities

  • Cerebras Systems Inc.

    AI chip maker listed on NASDAQ (CBRS).

  • Lie Sean

    Chief Technology Officer of Cerebras.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CBRSMed

Cerebras (CBRS) Plants A 165 MW Flag In Finland While Still Losing Money

Cerebras Systems (CBRS) announced a new AI data center in Finland with partner Compute Nordic Finland, set to reach 165 MW capacity. The project is backed by contracts and will be built in stages. Cerebras reported a 281% increase in cloud revenue for the quarter, but still operates at a loss. The company raised its full-year outlook but expects lower margins in the third quarter. Hedge fund ownership increased significantly, while short interest remains high.

$CBRSHighAI 8/10

Cerebras Drops 19% in 3 Months: Buy, Sell or Hold the Stock?

Cerebras Systems (CBRS) shares fell 19% in 3 months due to profitability concerns, margin pressure, and competition. Q3 2026 revenue guidance is $214-$216M, with margins expected to decline. The company faces customer concentration risks and competition from NVIDIA, AMD, and Intel. Despite strong RPO and expansion plans, near-term challenges persist. Analysts see a 56.93% upside potential.

$CBRSMedAI 8/10

Cerebras Has a $25.4 Billion Backlog, and One OpenAI Agreement Is Behind Much of It

Cerebras Systems reported Q2 adjusted revenue of $209.9M, up 103% YoY, with a $25.4B backlog driven by an OpenAI agreement. The company raised its full-year outlook to $880M-$890M. OpenAI's deal accounts for most of the backlog, with revenue recognition expected over several years. Cerebras' stock is down 44% from its 52-week high, trading at a market cap of ~$51B.

$CBRSHighAI 8/10

CBRS Stock Surges 68% On Nasdaq Debut: Cathie Wood's ARK Buys Shares While Trimming TSMC, AMD

Cerebras Systems (CBRS) shares surged 68% on their Nasdaq debut, closing at $311.07, with a market cap of $95B. ARK ETFs bought 105,616 shares, while trimming stakes in TSMC and AMD. The IPO raised $5.6B, with strong demand highlighting investor interest in AI hardware. CBRS reported $510M in 2023 sales, up from $290.3M in 2024, and partners with OpenAI, Meta, AWS, and IBM.